(:DPLO)

Business Focus: N/A

Nov 12, 2019 06:30 am ET

Diplomat Announces 3rd Quarter Financial Results; Updates 2019 Guidance

FLINT, Mich., Nov. 12, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial results for the quarter ended September 30, 2019. All comparisons, unless otherwise noted, are to the quarter ended September 30, 2018.

Oct 30, 2019 04:30 pm ET

Diplomat to Release Third-Quarter 2019 Operating Results Nov. 12

FLINT, Mich., Oct. 30, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) will release its third-quarter 2019 operating results before market open Tuesday, Nov. 12. A conference call and live webcast will be held at 8:30 a.m. ET.

Oct 16, 2019 04:30 pm ET

Diplomat Announces Sale of Certain Assets of Envoy Health Management, LLC to Diligent Health Solutions, LLC

FLINT, Mich., Oct. 16, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), effective today, has completed the sale of certain assets of Envoy Health Management, LLC to Diligent Health Solutions, LLC, a multifaceted healthcare communication center. Financial details and additional terms of the transaction were not disclosed.

Oct 02, 2019 04:30 pm ET

Diplomat Announces Promotion of David Skomo to Chief Operating Officer of CastiaRx

FLINT, Mich., Oct. 2, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has appointed David Skomo as chief operating officer of CastiaRx following the retirement of Chris Luthin. CastiaRx, a division of Diplomat, is a pharmacy benefit manager (PBM) that helps healthcare payers manage specialty pharmacy costs.

Aug 09, 2019 07:31 am ET

Diplomat Announces 2nd Quarter Financial Results; Updates 2019 Guidance

FLINT, Mich., Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial results for the quarter ended June 30, 2019. All comparisons, unless otherwise noted, are to the quarter ended June 30, 2018.

Aug 09, 2019 07:30 am ET

Diplomat Announces Review of Strategic Alternatives

FLINT, Mich., Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) today announced that its Board of Directors is reviewing strategic alternatives.

Aug 08, 2019 05:30 pm ET

Diplomat signs exclusive practice-based infusion agreement with Allergy Partners

FLINT, Mich., Aug. 8, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is pleased to announce an exclusive agreement between Diplomat and Allergy Partners, P.A., to manage in-office and in-home delivery and administration of infusion drugs and biologics. The agreement will cover treatments for primary immunodeficiency, alpha-1 antitrypsin deficiency, hereditary angioedema, and more.

Jul 18, 2019 04:30 pm ET

Diplomat to Release Second-Quarter 2019 Operating Results August 9

FLINT, Mich., July 18, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its second-quarter 2019 operating results before market open Friday, August 9. A conference call and live webcast will be held at 8:30 a.m. ET.

Jul 15, 2019 11:23 am ET

(DPLO) Alert: Johnson Fistel, LLP Announces Investigation of Diplomat Pharmacy, Inc.; Long Term Investors Encouraged to Contact Firm

SAN DIEGO, July 15, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential violations of federal and state laws by Diplomat Pharmacy, Inc. ("Diplomat") (NYSE: DPLO) and certain of its officers.

Jul 09, 2019 04:30 pm ET

Diplomat Launches Empower Ecosystem Patient Support Digital Library

FLINT, Mich., July 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), announced the launch of EMPOWER ECOSYSTEM, an online collection of services and tools to help patients and caregivers manage the physical, social, and emotional impact of their, or their loved ones, condition.

May 07, 2019 07:30 am ET

Diplomat Announces 1st Quarter Financial Results

FLINT, Mich., May 7, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial results for the quarter ended March 31, 2019. All comparisons, unless otherwise noted, are to the quarter ended March 31, 2018. Prior period financials have been recast to include certain direct expenses as part of cost of sales instead of selling, general and administrative expense for our Specialty segment. This change is a reclassification only and has no impact on overall results.

May 06, 2019 04:30 pm ET

Diplomat Appoints Dave Loschinskey as Chief Operating Officer

FLINT, Mich., May 6, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), announced today that the company's board of directors has appointed Dave Loschinskey to serve as chief operating officer effective May 2. In addition, Gary Rice will retire from his position as executive vice president of operations effective May 17, 2019.

Apr 30, 2019 07:15 am ET

NYSE: DPLO Investor Notice: Lawsuit against Diplomat Pharmacy Inc announced by Shareholders Foundation

The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in shares of Diplomat Pharmacy Inc (NYSE: DPLO). Investors, who purchased shares of Diplomat Pharmacy Inc (NYSE: DPLO), have certain options and should...

Apr 25, 2019 09:27 pm ET

APRIL 25 DEADLINE: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Diplomat Pharmacy, Inc. (DPLO) and Encourages DPLO Investors to Contact the Firm

Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all persons or entities who purchased or otherwise acquired Diplomat Pharmacy, Inc....

Apr 25, 2019 04:30 pm ET

Diplomat Using SMRxT Technology to Enhance Patient Care

FLINT, Mich., April 25, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is expanding its strategic relationship with medication adherence company SMRxT, creator of the Nomi® system.

Apr 25, 2019 02:06 pm ET

APRIL 25 DEADLINE: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Diplomat Pharmacy, Inc. (DPLO) and Encourages DPLO Investors to Contact the Firm

Apr 25, 2019 11:21 am ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DPLO, CVS, UMC and AAPL

The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...

Apr 25, 2019 08:30 am ET

THURSDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Diplomat Pharmacy, Inc. (“Diplomat” or “the Company”) (NYSE:

Apr 24, 2019 10:50 pm ET

DIPLOMAT PHARMACY 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Diplo

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until April 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Diplomat Pharmacy, Inc. (NYSE: DPLO). Investor losses must relate to purchases of the Company’s securities between February 26, 2018 and February 21, 2019, inclusive (the “Class Period”). This action is pending in the United States D

Apr 24, 2019 11:12 am ET

DEADLINE THURSDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Diplomat Pharmacy, Inc. (“Diplomat” or “the Company”) (NYSE: DPLO) for violations of §§10(b) and 20(a) of the Securities...

Apr 24, 2019 11:00 am ET

CLASS ACTION UPDATE for DPLO, WTW, EB and AAPL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...

Apr 23, 2019 06:23 pm ET

DPLO FINAL DEADLINE REMINDER: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of Important April 25th Deadline in Securities Class Action Filed by the Firm – DPLO

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Diplomat Pharmacy, Inc. (NYSE: DPLO) from February 26, 2018 through February 21, 2019, inclusive (the “Class Period”) of the April 25, 2019 lead plaintiff...

Apr 23, 2019 03:00 pm ET

Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...

Apr 22, 2019 11:49 am ET

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, WTW, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Diplomat Pharmacy, Inc. (DPLO)Class Period:...

Apr 19, 2019 10:50 pm ET

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, WTW, CTL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Apr 18, 2019 02:17 pm ET

DPLO DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. – DPLO

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Diplomat Pharmacy, Inc. (NYSE: DPLO) from February 26, 2018 through February 21, 2019, inclusive (the “Class Period”). The...

Apr 18, 2019 01:08 pm ET

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, CVS, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Apr 18, 2019 12:14 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline – DPLO

Pomerantz LLP announces that a class action lawsuit has been filed against Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE: DPLO) and certain of its officers and directors. The class action, filed in United States District Court,...

Apr 18, 2019 10:11 am ET

CLASS ACTION UPDATE for CORT, AVEO, DPLO and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Apr 18, 2019 06:00 am ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Health Insurance, Kraft Heinz, Diplomat, and Stamps.com and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Health Insurance Innovations, Inc., The Kraft Heinz Company, Diplomat Pharmacy, Inc., and Stamps.com Inc. Stockholders have...

Apr 17, 2019 04:30 pm ET

Diplomat to Release First-Quarter 2019 Operating Results May 7, Participate in Bank of America Merrill Lynch Healthcare Conference May 14

FLINT, Mich., April 17, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its first-quarter 2019 operating results before market open Tuesday, May 7. A conference call and live webcast will be held at 8:30 a.m. ET.

Apr 17, 2019 09:41 am ET

SHAREHOLDER ALERT: DPLO BV ZGNX MWA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...

Apr 16, 2019 10:46 am ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, DPLO, UMC and NIO

Apr 15, 2019 05:37 pm ET

DIPLOMAT APRIL 25th ALERT: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of Important Deadline in Securities Class Action Filed by the Firm – DPLO

Apr 15, 2019 05:10 pm ET

DPLO CLASS ACTION REMINDER: Hagens Berman Reminds Diplomat Pharmacy (DPLO) of Securities Class Action, Encourages Investors to Contact the Firm

SAN FRANCISCO, April 15, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP reminds investors in Diplomat Pharmacy, Inc. (NYSE: DPLO) of the pending securities class action and the April 25, 2019 Lead Plaintiff deadline. If you purchased or otherwise acquired Diplomat Pharmacy securities between February 26, 2018 and February 21, 2019 (the "class period") and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information about the case:

Apr 15, 2019 11:25 am ET

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, CVS, CTL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Apr 13, 2019 01:52 pm ET

INVESTOR ALERT: Kaskela Law LLC Announces Important April 2019 Shareholder Class Action Lawsuit Deadlines – BRS, TAP, CAG and DPLO

Kaskela Law LLC announces that shareholder class action lawsuits have been filed against Bristow Group Inc. (NYSE: BRS), Molson Coors Brewing Company (NYSE: TAP), Conagra Brands, Inc. (NYSE: CAG) and Diplomat Pharmacy, Inc. (NYSE: DPLO)....

Apr 12, 2019 10:50 pm ET

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, INGN, CVS, WTW INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Apr 12, 2019 03:00 pm ET

Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

Apr 11, 2019 08:30 am ET

New Research: Key Drivers of Growth for Lattice Semiconductor, W&T Offshore, Diplomat Pharmacy, SYNNEX, Marchex, and MEI Pharma — Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Lattice Semiconductor Corporation (NASDAQ:LSCC), W&T Offshore, Inc. (NYSE:WTI),...

Apr 11, 2019 06:00 am ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Health Insurance, Conagra, Kraft Heinz, and Diplomat and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Health Insurance Innovations, Inc., Conagra Brands, Inc., The Kraft Heinz Company, and Diplomat Pharmacy, Inc. Stockholders...

Apr 10, 2019 10:50 pm ET

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, MHLD, KHC, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Apr 10, 2019 10:39 pm ET

DPLO APRIL DEADLINE: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc.– DPLO

Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Diplomat Pharmacy, Inc. (NYSE: DPLO) from February 26, 2018 through February 21, 2019, inclusive. The lawsuit seeks to recover damages...

Apr 10, 2019 04:30 pm ET

Diplomat Expands AdhereTech Relationship as Program Shows Increased Adherence and Persistence

FLINT, Mich., April 10, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is expanding its relationship with AdhereTech to include more manufacturers' products. AdhereTech's smart pill bottles help to support patient adherence and persistence to prescribed medication regimens. The bottles also collect adherence data that should help Diplomat improve patient care.

Apr 09, 2019 08:41 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline -DPLO

NEW YORK, April 9, 2019 /CNW/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO) and certain of its officers and directors. The class action, filed in United States District Court, Central District of California, and indexed under 19-cv-01642, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who acquired Diplomat securities between February 26, 2018 through February 21, 2019, both dates inclusive (the "Class Period"), seeking to recover da

Apr 09, 2019 08:41 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline -DPLO

NEW YORK, April 9, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO) and certain of its officers and directors. The class action, filed in United States District Court, Central District of California, and indexed under 19-cv-01642, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who acquired Diplomat securities between February 26, 2018 through February 21, 2019, both dates inclusive (the "Class Period"), seeking to rec

Apr 09, 2019 04:30 pm ET

Diplomat Grants Chief Financial Officer Dan Davison Inducement Awards Pursuant to NYSE Rule 303A.08

FLINT, Mich., April 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) ("Diplomat" or the "Company") today announced that the Board of Directors (the "Board") has made certain equity awards to new chief financial officer and treasurer Dan Davison, effective April 8, 2019. The awards were made pursuant to the Company's previously announced employment agreement with Mr. Davison, and as a material inducement to his joining Diplomat as chief financial officer and treasurer.

Apr 09, 2019 04:00 pm ET

CLASS ACTION UPDATE for CORT, TAP, DPLO and USX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Apr 09, 2019 11:00 am ET

SHAREHOLDER ALERT: UXIN DPLO CNDT CRCM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Apr 08, 2019 07:07 pm ET

INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In AMRN, KHC, DPLO or VNDA To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, encourages investors in the following companies to contact the firm: Company: Amarin Corporation (NASDAQ:AMRN)Lead Plaintiff Deadline: April 23, 2019Class Period: September 24, 2018...

Apr 08, 2019 04:59 pm ET

CLASS ACTION UPDATE for AVEO, AVP, DPLO and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Apr 08, 2019 11:23 am ET

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, MHLD, KHC, CTL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Apr 08, 2019 10:50 am ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, TAP, DPLO and INGN

Apr 07, 2019 09:00 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline – DPLO

Apr 05, 2019 10:50 pm ET

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, MHLD, KHC, WTW INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Apr 05, 2019 08:10 pm ET

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed against Diplomat Pharmacy, Inc. and Encourages Investors to Contact the Firm before April 25

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE:

Apr 05, 2019 03:00 pm ET

Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

Apr 04, 2019 04:35 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Diplomat Pharmacy, Inc. to Contact the Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE:DPLO) of the April 25, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Apr 04, 2019 11:00 am ET

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of KHC, DPLO, CAG and SYNH

The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...

Apr 03, 2019 10:50 pm ET

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, MHLD, KHC, CVS INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Apr 03, 2019 11:12 am ET

CLASS ACTION UPDATE for T, DPLO, UMC and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Apr 02, 2019 06:13 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diplomat Pharmacy, Inc. ("Diplomat" or the "Company")(NYSE:DPLO) of the April 25, 2019 deadline to seek the role of lead plaintiff in a federal securities class...

Apr 02, 2019 05:32 pm ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MHLD, AVP, DPLO and ARA

Apr 01, 2019 04:48 pm ET

SHAREHOLDER ALERT: CORT DPLO CRBP ARA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Apr 01, 2019 11:44 am ET

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, MHLD, CAG, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Apr 01, 2019 10:39 am ET

CLASS ACTION UPDATE for BRS, DPLO, HCSG and INGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Mar 29, 2019 10:50 pm ET

DIPLOMAT PHARMACY SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Diplomat Pharmacy, Inc. - DPLO

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Diplomat Pharmacy, Inc. (NYSE: DPLO), if they purchased the Company’s securities between February 26, 2018 and February 21, 2019, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.

Mar 28, 2019 03:00 pm ET

Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

Mar 28, 2019 02:46 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline – DPLO

Mar 28, 2019 11:00 am ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SPB, SVXY, MHLD and DPLO

Mar 27, 2019 08:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Health Insurance, Conagra, Kraft Heinz, and Diplomat and Encourages Investors to Contact the Firm

Mar 27, 2019 01:57 pm ET

Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Actions Against Diplomat Pharmacy, Inc. (DPLO)

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, is notifying investors that class action lawsuits have been filed against Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE: DPLO), and certain other defendants,

Mar 26, 2019 06:14 pm ET

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DPLO, CVS, UMC and CNDT

Mar 26, 2019 11:47 am ET

DPLO: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc.– DPLO

Mar 25, 2019 03:49 pm ET

SHAREHOLDER ALERT: ARLO ZIV DPLO INGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Mar 25, 2019 02:09 pm ET

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Diplomat Pharmacy, Inc.

Law Offices of Howard G. Smith reminds investors of the upcoming April 25, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE: DPLO) securities between February 26, 2018 and February 21, 20

Mar 25, 2019 10:24 am ET

CLASS ACTION UPDATE for BRS, DPLO, BPI and CNDT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Mar 22, 2019 10:50 pm ET

DIPLOMAT PHARMACY SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

NEW ORLEANS, March 22, 2019 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Diplomat Pharmacy, Inc. (NYSE: DPLO), if they purchased the Company's securities between February 26, 2018 and February 21, 2019, inclusive (the "Class Period"). This action is pending in the United States District Court for the Central District of California.

Mar 22, 2019 08:35 pm ET

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Diplomat Pharmacy, Inc. and Encourages Investors to Contact the Firm Before April 25

Mar 22, 2019 04:56 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Diplomat Pharmacy, Inc. Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE: DPLO) securities between February 26, 2018 and February 21, 2019, inclusive (the “Class Period”). Diplomat investors have until

Mar 22, 2019 02:14 pm ET

Lifshitz & Miller LLP Announces Investigation of Amarin Corporation plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris The

NEW YORK, March 22, 2019 /PRNewswire/ --

Mar 21, 2019 06:06 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline – DPLO

Mar 21, 2019 03:00 pm ET

Bronstein, Gewirtz & Grossman, LLC Class Action Reminder Vanda Pharmaceuticals Inc. (VNDA), Stamps.com Inc. (STMP) & Diplomat Pharmacy, Inc. (DPLO) -

Mar 21, 2019 02:47 pm ET

DIPLOMAT INVESTOR ALERT: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors with Over $100K in Losses of Important Deadline in Securities Class Action Filed by the Firm – DPLO

Mar 20, 2019 08:49 pm ET

SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. – DPLO

Mar 20, 2019 01:16 pm ET

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of STMP, DPLO, CTL and BPI

Mar 20, 2019 09:37 am ET

CLASS ACTION UPDATE for TYME, KHC, DPLO and CTL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Mar 19, 2019 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Health Insurance, Conagra, Kraft Heinz, and Diplomat and Encourages Investors to Contact the Firm

Mar 19, 2019 06:07 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diplomat Pharmacy, Inc. ("Diplomat" or the "Company")(NYSE:DPLO) of the April 25, 2019 deadline to seek the role of lead plaintiff in a federal securities class...

Mar 19, 2019 12:13 pm ET

SHAREHOLDER ALERT: AVP DPLO VNDA CTL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Mar 17, 2019 10:07 am ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DPLO, SYNH, BPI and CNDT

Mar 17, 2019 09:30 am ET

INVESTOR ALERT: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of Important Deadline in Securities Class Action Filed by the Firm - DPLO

NEW YORK, March 17, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Diplomat Pharmacy, Inc. (NYSE: DPLO) from February 26, 2018 through February 21, 2019, inclusive (the "Class Period") of the April 25, 2019 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Diplomat investors under the federal securities laws.

Mar 15, 2019 10:50 pm ET

DIPLOMAT PHARMACY SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Diplomat Pharmacy, Inc. (NYSE: DPLO), if they purchased the Company’s securities between February 26, 2018 and February 21, 2019, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.

Mar 15, 2019 04:34 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

NEW YORK, March 15, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diplomat Pharmacy, Inc. ("Diplomat" or the "Company")(NYSE:DPLO) of the April 25, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Mar 15, 2019 02:00 pm ET

Johnson Fistel, LLP Files Class Action Suit against Diplomat Pharmacy, Inc.

SAN DIEGO, March 15, 2019 /PRNewswire/ -- Johnson Fistel, LLP announces that it has filed a class action lawsuit on behalf of all those who purchased or otherwise acquired Diplomat Pharmacy, Inc. ("Diplomat") (NYSE: DPLO) common stock during the period between February 26, 2018 through February 21, 2019, inclusive (the "Class Period"). This action was filed in the United States District Court for the Northern District of Illinois, case No. 1:19-cv-01735.

Mar 15, 2019 11:46 am ET

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of TYME, DPLO, CVS and SYNH

Mar 15, 2019 09:31 am ET

SECURITIES CLASS ACTION REMINDERS for TAP, SYNH, WRCDF and DPLO Investors: Hagens Berman Reminds Investors of Class Actions and Lead Plaintiff Deadlines

Hagens Berman Sobol Shapiro LLP reminds TAP, SYNH, WRCDF and DPLO investors of class action lawsuits, class periods, and Lead Plaintiff deadlines concerning the following companies. Molson Coors Brewing Company (NYSE: TAP)Class Period: February...

Mar 15, 2019 07:30 am ET

Diplomat Announces 4th Quarter and 2018 Year End Financial Results; Provides Revised 2019 Guidance

FLINT, Mich., March 15, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial results for the quarter and year ended December 31, 2018. All comparisons, unless otherwise noted, are to the quarter or year ended December 31, 2017. The Pharmacy Benefit Management ("PBM") segment comparisons are impacted by the timing of the Company's acquisitions, which occurred in late 2017. Prior period financials have been recast to include certain direct expenses as part of cost of sales instea

Mar 15, 2019 07:25 am ET

Diplomat Appoints Daniel Davison as Chief Financial Officer

FLINT, Mich., March 15, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), announced today that the company's board of directors has appointed Dan Davison as chief financial officer and treasurer effective April 8, succeeding Atul Kavthekar.

Mar 14, 2019 09:26 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline – DPLO

Mar 14, 2019 03:00 pm ET

(DPLO) Diplomat Pharmacy, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action & Deadline: April 25, 2019

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE: DPLO) and certain of its officers, on behalf of...

Mar 13, 2019 05:19 pm ET

SHAREHOLDER ALERT: DPLO CAG CVS CTL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Mar 13, 2019 04:30 pm ET

Diplomat Announces Details of Rescheduled 2018 Results Conference Call

FLINT, Mich., March 13, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will report its fourth-quarter and year-end 2018 financial results, as well as provide 2019 guidance, before market open Friday, March 15. A conference call and live webcast will follow at 8 a.m. ET.

Mar 12, 2019 03:34 pm ET

DPLO DEADLINE ALERT: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc.– DPLO

Mar 11, 2019 06:48 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Diplomat Pharmacy, Inc. Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Diplomat Pharmacy, Inc. investors (“Diplomat” or the “Company”) (NYSE: DPLO) concerning the Company and its officers’ possible violations of federal securities laws. On...

Mar 11, 2019 06:02 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diplomat Pharmacy, Inc. ("Diplomat" or the "Company")(NYSE:DPLO) of the April 25, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Mar 11, 2019 05:50 pm ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of STMP, DPLO, BPI and USX

Mar 11, 2019 04:45 pm ET

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Mar 10, 2019 09:10 am ET

(DPLO) Alert: Johnson Fistel, LLP Reminds Investors of Deadline in the Class Action Lawsuit Against Diplomat Pharmacy, Inc.

SAN DIEGO, March 10, 2019 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP reminds investors that a class action lawsuit has been filed against Diplomat Pharmacy, Inc. ("Diplomat") (NYSE: DPLO) on behalf of all purchasers of common stock during the period between February 26, 2018 through February 21, 2019, inclusive (the "Class Period").

Mar 08, 2019 10:50 pm ET

DIPLOMAT PHARMACY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

Mar 08, 2019 10:02 pm ET

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact th

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Diplomat Pharmacy, Inc. (“Diplomat” or “the Company”) (NYSE:

Mar 08, 2019 12:00 pm ET

(DPLO) Diplomat Pharmacy, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action & Deadline: April 25, 2019

Mar 08, 2019 09:15 am ET

SHAREHOLDER ALERT: SVXY MHLD TAP DPLO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Mar 07, 2019 05:39 pm ET

DPLO DEADLINE ALERT: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of Important April 25th Deadline in Securities Class Action Commenced by the Firm – DPLO

Mar 07, 2019 04:10 pm ET

DIPLOMAT PHARMACY, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Ce

Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired...

Mar 07, 2019 03:09 pm ET

Pomerantz Law Firm Announces the Filing of a Class Action against Diplomat Pharmacy, Inc. and Certain Officers – DPLO

Mar 07, 2019 08:00 am ET

Diplomat Pharmacy, Inc. Investor Alert: Law Offices of Andrew J. Brown Investigates Possible Violations of Federal Securities Laws by Officers and Directors

Nationally recognized securities attorney Andrew J. Brown, founder of The Law Offices of Andrew J. Brown, announces an investigation into legal claims against the officers and Board of Directors of Diplomat Pharmacy, Inc. (NYSE:DPLO).More...

Mar 05, 2019 10:53 am ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SOGO, STMP, DPLO and SYNH

Mar 04, 2019 03:15 pm ET

EnvoyHealth to Offer Mango Health Mobile App

FLINT, Mich., March 4, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), subsidiary EnvoyHealth has partnered with Mango Health to offer pharmaceutical manufacturer clients access to a custom mobile app for patient engagement and medication management.

Mar 04, 2019 11:32 am ET

CLASS ACTION UPDATE for DPLO and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Mar 03, 2019 06:20 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Diplomat Pharmacy, Vanda Pharmaceuticals, and AVEO Pharmaceuticals and Encourages Investors to Contact

Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Diplomat Pharmacy, Inc., Vanda Pharmaceuticals Inc., and AVEO Pharmaceuticals, Inc. Stockholders have until the deadlines...

Mar 01, 2019 11:50 pm ET

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the F

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Diplomat Pharmacy, Inc. (“Diplomat” or “the Company”) (NYSE:

Mar 01, 2019 10:00 pm ET

INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc.

Mar 01, 2019 09:50 pm ET

DIPLOMAT PHARMACY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit

NEW ORLEANS, March 1, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Diplomat Pharmacy, Inc. (NYSE: DPLO), if they purchased the Company's securities between February 26, 2018 and February 21, 2019, inclusive (the "Class Period"). This action is pending in the United States District Court for the Central District of California.

Mar 01, 2019 04:02 pm ET

SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. – DPLO

Mar 01, 2019 12:00 pm ET

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, STMP and DPLO

Mar 01, 2019 09:30 am ET

DPLO CLASS ACTION ALERT: Hagens Berman Alerts Diplomat Pharmacy (DPLO) Investors to April 25, 2019 Securities Class Action Lead Plaintiff Deadline

Hagens Berman Sobol Shapiro LLP alerts investors in Diplomat Pharmacy, Inc. (NYSE: DPLO) to the April 25, 2019 Lead Plaintiff deadline in the securities class action pending in the United States District Court for the Central District of...

Feb 28, 2019 12:37 pm ET

SHAREHOLDER ALERT: SOGO AXGN W DPLO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Feb 28, 2019 07:30 am ET

Diplomat Announces Resignation of Jeff Park from Board of Directors

FLINT, Mich., Feb. 28, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), announced today that the Company's board of directors accepted the resignation of director Jeff Park, effective Feb. 22, 2019. Mr. Park has been a member of Diplomat's board of directors since June 2017. He served as interim CEO of Diplomat from January to May 2018.

Feb 27, 2019 05:34 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Diplomat Pharmacy, Inc. Investors

Feb 27, 2019 04:05 pm ET

DIPLOMAT PHARMACY, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the

Feb 27, 2019 03:32 pm ET

CLASS ACTION UPDATE for MU, AVEO, DPLO and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Feb 27, 2019 12:43 pm ET

CLASS ACTION UPDATE for YRIV, W, DPLO and CAG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Feb 26, 2019 05:10 pm ET

CLASS ACTION UPDATE for ARLO, ATVI, AVP and DPLO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Feb 26, 2019 02:59 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Diplomat Pharmacy, Inc. to Contact the Firm

Feb 26, 2019 02:26 pm ET

CLASS ACTION UPDATE for SOGO, MU, SVXY and DPLO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Feb 26, 2019 11:43 am ET

CLASS ACTION UPDATE for YRCW, W, SVXY and DPLO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Feb 26, 2019 10:35 am ET

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MU, MHLD, DPLO and AMRN

Feb 25, 2019 08:12 pm ET

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Diplomat Pharmacy, Inc. (DPLO) and Encourages DPLO Investors to Contact the Firm

Feb 25, 2019 07:41 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Diplomat Pharmacy, Inc. - DPLO

NEW YORK, Feb. 25, 2019 /CNW/ -- Pomerantz LLP is investigating claims on behalf of investors of Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.

Feb 25, 2019 07:41 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Diplomat Pharmacy, Inc. - DPLO

NEW YORK, Feb. 25, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.

Feb 25, 2019 06:29 pm ET

DPLO CLASS ACTION ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

NEW YORK, Feb. 25, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Diplomat Pharmacy, Inc. (NYSE: DPLO) from February 26, 2018 through February 21, 2019, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Diplomat investors under the federal securities laws.

Feb 25, 2019 05:33 pm ET

CLASS ACTION UPDATE for UXIN, GE, MHLD and DPLO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Feb 25, 2019 03:49 pm ET

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc.

Federman & Sherwood announces that on February 24, 2019, a class action lawsuit was filed in the United States District Court for the Central District of California against Diplomat Pharmacy, Inc. (NYSE: DPLO). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is Febru

Feb 25, 2019 02:23 pm ET

CLASS ACTION UPDATE for MAXR, ATVI, ASTE and DPLO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Feb 25, 2019 12:34 pm ET

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Diplomat Pharmacy, Inc. (DPLO)

Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Diplomat Pharmacy, Inc. (“Diplomat Pharmacy” or the “Company”) (NYSE: DPLO) in the United States District Court for the Central District of California on behalf...

Feb 25, 2019 12:09 pm ET

DIPLOMAT PHARMACY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit

Feb 24, 2019 07:25 pm ET

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. – DPLO

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Diplomat Pharmacy, Inc. (NYSE:DPLO) from February 26, 2018 through February 21, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Diplomat investors under the federal securities laws.

Feb 24, 2019 09:26 am ET

DPLO LOSSES ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Diplomat Pharmacy, Inc.; Investors are Encouraged to Contact the Firm – DPLO

Rosen Law Firm, a global investor rights law firm, is continuing to investigate potential securities claims on behalf of shareholders of Diplomat Pharmacy, Inc. (NYSE: DPLO) resulting from allegations that Diplomat may have issued materially...

Feb 23, 2019 12:58 am ET

Investor Alert: Kaplan Fox Announces Investigation Of Diplomat Pharmacy, Inc.

NEW YORK, Feb. 23, 2019 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Diplomat Pharmacy, Inc. ("Diplomat Pharmacy" or the "Company") (NYSE: DPLO), a specialty pharmacy company. Investors who purchased or otherwise acquired Diplomat Pharmacy's publicly traded securities may be affected.

Feb 22, 2019 10:50 pm ET

DIPLOMAT PHARMACY INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Diplomat Pharmacy, Inc. for Possible Securities Fraud - DPLO

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Diplomat Pharmacy, Inc. (NYSE: DPLO).

Feb 22, 2019 06:23 pm ET

Bragar Eagel & Squire, P.C. is Investigating Diplomat Pharmacy, Inc. (DPLO) on Behalf of Stockholders and Encourages DPLO Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against Diplomat Pharmacy, Inc. (NYSE: DPLO). Our investigation concerns whether Diplomat has violated the federal securities laws and/or engaged in other unlawful business practices....

Feb 22, 2019 03:23 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Diplomat Pharmacy, Inc.

Levi & Korsinsky announces it has commenced an investigation of Diplomat Pharmacy, Inc. (“Diplomat” or “the Company”) (NYSE: DPLO) concerning possible violations of federal securities laws. On February 22, 2019, DPLO issued a press release...

Feb 22, 2019 02:06 pm ET

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Diplomat Pharmacy, Inc. – DPLO

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Diplomat Pharmacy, Inc. (NYSE: DPLO) resulting from allegations that Diplomat may have issued materially misleading business information to the investing public.

Feb 22, 2019 01:09 pm ET

Former California Deputy Attorney General and Special Counsel with Johnson Fistel Launches Investigation into Diplomat Pharmacy (DPLO); Investors Suffering Losses Encouraged to Contact Firm

SAN DIEGO, Feb. 22, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP with the assistance of former California Deputy Attorney General and Special Counsel, Tiffany Johnson, Esq., is investigating potential claims against Diplomat Pharmacy, Inc. ("Diplomat") (NYSE: DPLO) for violations of state and federal securities laws.

Feb 22, 2019 12:16 pm ET

SHAREHOLDER ALERT: Investigation of Diplomat Pharmacy Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC is investigating whether certain statements made by Diplomat Pharmacy, Inc. (“Diplomat Pharmacy” or the “Company”)(NASDAQ: DPLO) complied with federal securities laws. On February 22, 2019, Diplomat Pharmacy announced that it was delaying its financial results following a determination that the Company will need to record a non-cash impairment charge. The price of Diplomat Pharmacy stock declined following the news.

Feb 22, 2019 07:30 am ET

Diplomat Delays Release of 2018 Financial Results and Filing of 10-K

FLINT, Mich., Feb. 22, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), announced today that it is postponing the release of its fourth-quarter and full-year 2018 financial results and the related conference call and webcast to March 15, 2019. The Company expects to file its annual report on Form 10-K for the fiscal year ended December 31, 2018 soon afterwards.

Feb 12, 2019 07:10 am ET

Diplomat to Present at Investor Conferences in February, March 2019

FLINT, Mich., Feb. 12, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) executives will participate in four upcoming investor conferences.

Jan 28, 2019 07:05 am ET

Diplomat to Release 2018 Financial Results, 2019 Guidance Feb. 25

FLINT, Mich., Jan. 28, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will report its fourth-quarter and year-end 2018 financial results — and provide 2019 guidance — after market close Monday, Feb. 25. A conference call and live webcast will follow at 5 p.m. ET.

Jan 10, 2019 07:25 am ET

Recent Analysis Shows T-Mobile US, Thor Industries, Integra LifeSciences, Diplomat Pharmacy, Tile Shop Hldgs, and Compass Diversified Market Influences — Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of T-Mobile US, Inc. (NASDAQ:TMUS), Thor Industries, Inc. (NYSE:THO), Integra...

Jan 07, 2019 07:10 am ET

Diplomat Provides Updated 2018 Guidance and Preliminary 2019 Outlook

FLINT, Mich., Jan. 7, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is updating its 2018 financial guidance and providing a preliminary 2019 outlook in connection with its presentation today at the JP Morgan Healthcare Conference in San Francisco.

Jan 07, 2019 06:50 am ET

Diplomat Partners With CSI Specialty Group to Expand Health System Services

FLINT, Mich., Jan. 7, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), and CSI Specialty Group, a globally recognized specialty pharmacy consulting firm, have launched a program for hospitals and health systems interested in starting or expanding their own specialty pharmacy services to benefit from Diplomat's limited-distribution drug portfolio and expertise treating rare, chronic, and complex diseases.

Jan 07, 2019 06:40 am ET

Diplomat Named Exclusive Specialty Partner for Hospitality Rx

FLINT, Mich., Jan. 7, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has been selected by Hospitality Rx as the exclusive provider of specialty pharmacy and infusion services for its UNITE HERE HEALTH (UHH) plan members.

Dec 19, 2018 07:00 am ET

Diplomat to Participate in 37th Annual J.P. Morgan Healthcare Conference

FLINT, Mich., Dec. 19, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), executives will present at this year's J.P. Morgan Healthcare Conference in San Francisco.

Nov 29, 2018 12:34 pm ET

TemperPack partners with Diplomat to bring curbside recyclable insulation to Life Science shipments

RICHMOND, Va., Nov. 29, 2018 /PRNewswire/ -- Diplomat Pharmacy, the largest independent provider of specialty pharmacy services in the United States, has committed to moving their cold chain shipments away from EPS foam by utilizing TemperPack's ClimaCell™ insulating technology.

Nov 28, 2018 07:55 am ET

Diplomat Selects Inovalon’s Specialty Pharmacy Platform

Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced a multi-year deal with Diplomat (NYSE: DPLO), the nation’s largest independent provider of specialty...

Nov 26, 2018 03:05 pm ET

Diplomat Switches to Fully Recyclable Packaging for Temperature-Sensitive Medication

FLINT, Mich., Nov. 26, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is now shipping temperature-sensitive medication in ClimaCell™ coolers from TemperPack.

Nov 09, 2018 08:25 am ET

New Research Coverage Highlights Harmonic, ScanSource, Clean Energy Fuels, American Software, Diplomat Pharmacy, and Quidel — Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Harmonic Inc. (NASDAQ:HLIT), ScanSource, Inc. (NASDAQ:SCSC), Clean...

Nov 06, 2018 03:15 pm ET

Diplomat Announces 3rd Quarter Financial Results

FLINT, Mich., Nov. 6, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy services, announced financial results for the quarter ended September 30, 2018. All comparisons, unless otherwise noted, are to the quarter ended September 30, 2017. Prior period financials have been recast to include certain direct expenses as part of cost of sales instead of selling, general and administrative ("SG&A") expense for our specialty segment. This change is a reclassification only and has no impact on overall results.

Oct 16, 2018 04:15 pm ET

Diplomat to Release Third-Quarter 2018 Operating Results, Host Conference Call on Nov. 6

FLINT, Mich., Oct. 16, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its third-quarter 2018 operating results after market close Tuesday, Nov. 6, with a conference call to follow at 5 p.m. ET.

Oct 09, 2018 08:30 am ET

Market Trends Toward New Normal in Diplomat Pharmacy, Senior Housing Properties Trust, FARO Technologies, Endurance International Group, PolyOne, and NorthWestern — Emerging Consolidated Expectations,

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Diplomat Pharmacy, Inc. (NYSE:DPLO), Senior Housing Properties Trust...

Sep 27, 2018 08:05 am ET

Diplomat Opens Facility in Arizona

FLINT, Mich., Sept. 27, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has opened a 75,000-square-foot facility in Chandler, Arizona, to bolster pharmacy operations and ensure business continuity.

Aug 30, 2018 04:05 pm ET

Diplomat to Participate in Upcoming Investor Conferences

FLINT, Mich., Aug. 30, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), executives will present at three upcoming investor conferences.

Aug 06, 2018 04:15 pm ET

Diplomat Announces 2nd Quarter Financial Results

FLINT, Mich., Aug. 6, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy services, announced financial results for the quarter ended June 30, 2018. All comparisons, unless otherwise noted, are to the quarter ended June 30, 2017. Prior period financials have been recast to include certain direct expenses as part of cost of sales instead of selling, general and administrative expense ("SG&A") for our specialty segment. This change is a reclassification only and has no impact on overall results.

Aug 02, 2018 07:30 am ET

Consolidated Research: 2018 Summary Expectations for CVB Financial, Commercial Vehicle Group, Donaldson, Easterly Government Properties, Diplomat Pharmacy, and Five9 — Fundamental Analysis, Key Perfor

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CVB Financial Corporation (NASDAQ:CVBF), Commercial Vehicle Group, Inc....

Jul 23, 2018 07:45 am ET

Diplomat to Release Second-Quarter 2018 Operating Results, Host Conference Call on Aug. 6

FLINT, Mich., July 23, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its second-quarter 2018 operating results after market close Monday, Aug. 6, with a conference call to follow at 5 p.m. ET.

Jun 05, 2018 05:18 pm ET

Diplomat Grants CEO Brian Griffin Inducement Awards Pursuant To NYSE Rule 303A.08

FLINT, Mich., June 5, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) ("Diplomat" or the "Company") today announced that the Compensation Committee (the "Compensation Committee") of the Board of Directors (the "Board") has made certain equity awards to new CEO Brian Griffin, effective June 4, 2018. The awards were made pursuant to the Company's previously-announced employment agreement with Mr. Griffin, and as a material inducement to his joining Diplomat as CEO and Chairman of the Board.

May 10, 2018 08:35 am ET

Diplomat Pharmacy Appoints Brian Griffin as Chief Executive Officer and Chairman of the Board

FLINT, Mich., May 10, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) ("Diplomat" or the "Company") today announced that its Board of Directors has appointed Brian Griffin, Executive Vice President and CEO of IngenioRx, the pharmacy benefit manager (PBM) of Anthem, Inc. (NYSE: ANTM), as Chief Executive Officer and Chairman of the Board of Directors, effective June 4, 2018.

May 08, 2018 07:00 am ET

Diplomat Pharmacy in Final Stages of CEO Search Process

FLINT, Mich., May 8, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) ("Diplomat" or the "Company") today announced that the Board is in the final stages of its search process for a permanent CEO and expects to name Diplomat's next CEO by the end of this week. The Company also announced that Jeff Park has resigned voluntarily as Interim CEO, effective Friday, May 11, 2018, but will remain a director on Diplomat's Board. After Mr. Park steps down, Atul Kavthekar, CFO of Diplomat, will temporarily assume the additional responsibilities of the CEO until the appointment of the new CEO

May 07, 2018 04:38 pm ET

Diplomat Announces Strong 1st Quarter Financial Results

FLINT, Mich., May 7, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy services, announced financial results for the quarter ended March 31, 2018. All comparisons, unless otherwise noted, are to the quarter ended March 31, 2017.

May 01, 2018 04:15 pm ET

Diplomat to Participate in 43rd Annual Deutsche Bank Health Care Conference

FLINT, Mich., May 1, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), executives will attend the 43rd Annual Deutsche Bank Health Care Conference in Boston.

Apr 30, 2018 08:00 am ET

Diplomat Launches CastiaRx, Industry-Leading Specialty Benefit Manager

FLINT, Mich., April 30, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has unveiled CastiaRx to respond to industry demand for a leader in specialty benefit management.

Apr 23, 2018 04:15 pm ET

Diplomat to Release Q1 2018 Operating Results, Host Conference Call on May 7

FLINT, Mich., April 23, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its first-quarter 2018 operating results after market close Monday, May 7, with a conference call to follow at 5 p.m. ET.

Apr 23, 2018 08:20 am ET

Detailed Research: Economic Perspectives on Craft Brew Alliance, Herc, Diplomat Pharmacy, Western Gas Partners, LP, Stag Industrial, and Genesee & Wyoming — What Drives Growth in Today's Competitive L

NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Craft Brew Alliance, Inc. (NASDAQ:BREW), Herc...

Mar 19, 2018 04:15 pm ET

Diplomat to Present at 2018 Needham & Company Healthcare Conference

FLINT, Mich., March 19, 2018 /PRNewswire/ -- Diplomat Pharmacy Inc. (NYSE: DPLO) will participate in Needham & Company's 17th annual healthcare conference in New York City.

Mar 13, 2018 04:35 pm ET

Rockwell Medical, Inc. Appoints Two Independent and Experienced Life Sciences Executives to Board of Directors

Lisa Colleran and Benjamin Wolin Unanimously Appointed to Rockwell Board

Mar 13, 2018 12:59 pm ET

Diplomat to Present at 2018 Barclays Global Healthcare Conference

FLINT, Mich., March 13, 2018 /PRNewswire/ -- Diplomat Pharmacy Inc. (NYSE: DPLO) will send executives to the 2018 Barclays Global Healthcare Conference in Miami, Florida.

Mar 08, 2018 11:00 am ET

Dance Biopharm Elects Benjamin Wolin to Board of Directors

Dance Biopharm Holdings Inc. ("Dance"), a privately-held biotechnology company focused on the development of Dance 501, a proprietary 'soft-mist' inhaled insulin product to treat diabetes, is pleased to announce the appointment of Benjamin Wolin to...

Feb 26, 2018 03:33 pm ET

Diplomat Announces 4th Quarter and 2017 Year End Financial Results; Provides 2018 Guidance

FLINT, Mich., Feb. 26, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy services, announced financial results for the quarter and year ended December 31, 2017. All comparisons, unless otherwise noted, are to the quarter or year ended December 31, 2016.

Feb 26, 2018 01:15 pm ET

Diplomat Pharmacy, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 26, 2018 / Diplomat Pharmacy, Inc. (NYSE: DPLO) will be discussing their earnings results in their Q4 Earnings Call to be held on February 26, 2018 at 5:00 PM Eastern Time.

Feb 22, 2018 07:50 am ET

Report: Developing Opportunities within Diplomat Pharmacy, Cogent Communications, Western Asset Mortgage Capital, Kimberly-Clark, Cincinnati Financial, and Cherry Hill Mortgage Investment - Future Exp

NEW YORK, Feb. 22, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Diplomat Pharmacy, Inc. (NYSE:DPLO), Cogent Communications...

Feb 21, 2018 04:30 pm ET

Diplomat Managing Rising Drug Costs to Support Patients

FLINT, Mich., Feb. 21, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) plans to combat rising healthcare costs throughout 2018 by advancing generic drugs, biosimilars, and affordable brand medications.

Feb 20, 2018 04:16 pm ET

Diplomat to Release Fourth Quarter and 2017 Year End Financial Results, Provide 2018 Guidance and Host Conference Call On Monday, February 26, 2018

FLINT, Mich., Feb. 20, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it will release its fourth quarter and 2017 year end financial results and provide 2018 guidance on Monday, February 26, 2018 after market close, with a conference call to follow at 5:00 p.m. ET.

Jan 29, 2018 03:15 pm ET

ThriveRx Wins ASPEN Clinical Nutrition Team of Distinction Award

CINCINNATI, Jan. 29, 2018 /PRNewswire/ -- ThriveRx, the nutrition division of Diplomat Specialty Infusion Group, has been named a 2018 Clinical Nutrition Team of Distinction by the American Society for Parenteral and Enteral Nutrition (ASPEN).

Jan 15, 2018 03:15 pm ET

Diplomat Dispensing Advanced Kidney Treatment, CABOMETYX®

FLINT, Mich., Jan. 15, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) is dispensing Exelixis' limited-distribution treatment CABOMETYX® (cabozantinib), now with an expanded indication.

Jan 05, 2018 07:31 am ET

Diplomat Initiates CEO Transition; Reaffirms 2017 Guidance and Provides Preliminary 2018 Outlook

FLINT, Mich., Jan. 5, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) ("Diplomat" or the "Company") today announced that Jeff Park, a member of the Diplomat Board of Directors, has been appointed Interim Chief Executive Officer, effective immediately. Mr. Park's appointment follows the retirement of Phil Hagerman, co-founder of Diplomat in 1975 and Chief Executive Officer and Chairman of Diplomat since 1991. Mr. Hagerman will remain as a member of the Diplomat Board and become Chairman Emeritus. The Board has appointed Ben Wolin, independent Lead Director, as Chairman of the Diplom

Jan 05, 2018 07:30 am ET

Diplomat Reaffirms 2017 Guidance, Provides Preliminary 2018 Outlook

FLINT, Mich., Jan. 5, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) has reaffirmed guidance for the full-year 2017 and provided a preliminary 2018 outlook.

Dec 20, 2017 03:15 pm ET

Diplomat Completes Acquisition of LDI Integrated Pharmacy Services, Secures New Credit Facilities

FLINT, Mich., Dec. 20, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has completed its acquisition of Leehar Distributors, LLC, doing business as LDI Integrated Pharmacy Services, from Nautic Partners, LLC; Oak HC/FT Partners, L.P.; and LDI management.

Dec 20, 2017 09:00 am ET

Diplomat to Participate in 36th Annual J.P. Morgan Healthcare Conference

FLINT, Mich., Dec. 20, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has announced that Phil Hagerman, CEO and chairman, and Atul Kavthekar, CFO, will present at the upcoming 36th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Dec 11, 2017 03:15 pm ET

Diplomat Adds Chris Luthin as Executive Vice President

FLINT, Mich., Dec. 11, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has hired Chris Luthin to serve its pharmacy benefit manager (PBM) arm as executive vice president of finance, pharmacy benefit management, and integration.

You are here

(:DPLO)

Business Focus: N/A